Literature DB >> 16078132

The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Chantal Csajka1, David Drover, Davide Verotta.   

Abstract

PURPOSE: The aim of this study was to evaluate the utility of a parametric deconvolution method using a sum of inverse Gaussian functions (IG) to characterize the absorption and concentrations vs. time profile of drugs exhibiting complex absorption.
METHODS: For a linear time-invariant system the response, Y(t), following an arbitrary input function I(t), is the convolution of I(t) with the disposition function, H(t), of the system: [Formula: see text]. The method proposed uses a sum of n inverse Gaussian functions to characterize I(t). The approach was compared with a standard nonparametric method using linear splines. Data were provided from previously published studies on two drugs (hydromorphone and veralipride) showing complex absorption and analyzed with NONMEM.
RESULTS: A satisfactory fit for hydromorphone and veralipride data following oral administration was achieved by fitting a sum of two or three IG functions. The predictions of the input functions were very similar to those using linear splines.
CONCLUSIONS: The use of a sum of IG as opposed to nonparametric functions, such as splines, offers a simpler implementation, a more intuitive interpretation of the results, a built-in extrapolation, and an easier implementation in a population context. Disadvantages are an apparent greater sensitivity to initial value estimates (when used with NONMEM).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078132     DOI: 10.1007/s11095-005-5266-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Time-dependent oral absorption models.

Authors:  K Higaki; S Yamashita; G L Amidon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-04       Impact factor: 2.745

Review 2.  Pharmacokinetic strategies in deciphering atypical drug absorption profiles.

Authors:  Honghui Zhou
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

3.  Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

Authors:  David R Drover; Martin S Angst; Marta Valle; Bhamini Ramaswamy; Sujata Naidu; Donald R Stanski; Davide Verotta
Journal:  Anesthesiology       Date:  2002-10       Impact factor: 7.892

Review 4.  Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems.

Authors:  D Verotta
Journal:  Crit Rev Biomed Eng       Date:  1996

5.  A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.

Authors:  Y Plusquellec; G Campistron; S Staveris; J Barre; L Jung; J P Tillement; G Houin
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

6.  The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.

Authors:  R L Oberle; G L Amidon
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

Review 7.  Gastrointestinal absorption of drugs.

Authors:  L F Prescott
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

8.  Discontinuous absorption processes in pharmacokinetic models.

Authors:  R Süverkrüp
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

9.  A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters.

Authors:  K Ishii; Y Katayama; S Itai; Y Ito; H Hayashi
Journal:  Biol Pharm Bull       Date:  1995-06       Impact factor: 2.233

10.  Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal.

Authors:  W R Gillespie; P Veng-Pedersen; M J Berg; D D Schottelius
Journal:  J Pharmacokinet Biopharm       Date:  1986-02
View more
  16 in total

1.  A note on population analysis of dissolution-absorption models using the inverse Gaussian function.

Authors:  Jian Wang; Michael Weiss; David Z D'Argenio
Journal:  J Clin Pharmacol       Date:  2008-03-21       Impact factor: 3.126

2.  Implementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model).

Authors:  Jun Shen; Alison Boeckmann; Andrew Vick
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-04       Impact factor: 2.745

3.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

4.  Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.

Authors:  Josef A Vogt; Christian Denzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-02       Impact factor: 2.745

5.  A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery.

Authors:  François Gaudreault; Pierre Drolet; Michel Fallaha; France Varin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-09-30       Impact factor: 2.745

6.  A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies.

Authors:  Shuhua Hu; Michael Dunlavey; Serge Guzy; Nathan Teuscher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-01-24       Impact factor: 2.745

7.  Effect of Activated Charcoal on Rivaroxaban Complex Absorption.

Authors:  Edouard Ollier; Sophie Hodin; Julien Lanoiselée; Jean Escal; Sandrine Accassat; Elodie De Magalhaes; Thierry Basset; Laurent Bertoletti; Patrick Mismetti; Xavier Delavenne
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

8.  Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformations.

Authors:  Nikolaos Tsamandouras; Thierry Wendling; Amin Rostami-Hodjegan; Aleksandra Galetin; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-05-26       Impact factor: 2.745

9.  Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects.

Authors:  Thierry Wendling; Kayode Ogungbenro; Etienne Pigeolet; Swati Dumitras; Ralph Woessner; Leon Aarons
Journal:  Pharm Res       Date:  2014-11-26       Impact factor: 4.200

10.  Application of Deep Neural Networks as a Prescreening Tool to Assign Individualized Absorption Models in Pharmacokinetic Analysis.

Authors:  Mutaz M Jaber; Burhaneddin Yaman; Kyriakie Sarafoglou; Richard C Brundage
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.